nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—Clopidogrel—coronary artery disease	0.0561	0.109	CbGbCtD
Ropivacaine—SCN5A—purkinje fiber—coronary artery disease	0.0387	0.419	CbGeAlD
Ropivacaine—CYP1A2—Gemfibrozil—coronary artery disease	0.0379	0.0735	CbGbCtD
Ropivacaine—CYP2B6—Simvastatin—coronary artery disease	0.0336	0.0651	CbGbCtD
Ropivacaine—CYP1A2—Clopidogrel—coronary artery disease	0.0329	0.0637	CbGbCtD
Ropivacaine—CYP2B6—Atorvastatin—coronary artery disease	0.03	0.0581	CbGbCtD
Ropivacaine—CYP3A4—Ticagrelor—coronary artery disease	0.0279	0.0541	CbGbCtD
Ropivacaine—CYP3A4—Fenofibrate—coronary artery disease	0.0249	0.0482	CbGbCtD
Ropivacaine—CYP2D6—Niacin—coronary artery disease	0.0205	0.0398	CbGbCtD
Ropivacaine—SCN5A—endocardium—coronary artery disease	0.0199	0.216	CbGeAlD
Ropivacaine—CYP3A4—Gemfibrozil—coronary artery disease	0.0199	0.0385	CbGbCtD
Ropivacaine—CYP2D6—Timolol—coronary artery disease	0.0191	0.037	CbGbCtD
Ropivacaine—SCN5A—sinoatrial node—coronary artery disease	0.0189	0.204	CbGeAlD
Ropivacaine—CYP3A4—Clopidogrel—coronary artery disease	0.0172	0.0334	CbGbCtD
Ropivacaine—CYP2D6—Captopril—coronary artery disease	0.0168	0.0326	CbGbCtD
Ropivacaine—CYP2D6—Simvastatin—coronary artery disease	0.0162	0.0315	CbGbCtD
Ropivacaine—CYP1A2—Losartan—coronary artery disease	0.0161	0.0311	CbGbCtD
Ropivacaine—CYP3A4—Eplerenone—coronary artery disease	0.016	0.031	CbGbCtD
Ropivacaine—CYP2D6—Lovastatin—coronary artery disease	0.0159	0.0308	CbGbCtD
Ropivacaine—CYP2D6—Pravastatin—coronary artery disease	0.0159	0.0308	CbGbCtD
Ropivacaine—CYP2D6—Atorvastatin—coronary artery disease	0.0145	0.028	CbGbCtD
Ropivacaine—CYP3A4—Enalapril—coronary artery disease	0.0143	0.0277	CbGbCtD
Ropivacaine—CYP3A4—Ezetimibe—coronary artery disease	0.0111	0.0215	CbGbCtD
Ropivacaine—CYP3A4—Rosuvastatin—coronary artery disease	0.0111	0.0215	CbGbCtD
Ropivacaine—CYP3A4—Simvastatin—coronary artery disease	0.0103	0.02	CbGbCtD
Ropivacaine—CYP3A4—Lovastatin—coronary artery disease	0.0101	0.0196	CbGbCtD
Ropivacaine—CYP3A4—Pravastatin—coronary artery disease	0.0101	0.0196	CbGbCtD
Ropivacaine—CYP3A4—Atorvastatin—coronary artery disease	0.0092	0.0178	CbGbCtD
Ropivacaine—CYP3A4—Losartan—coronary artery disease	0.00842	0.0163	CbGbCtD
Ropivacaine—SCN5A—cardiac ventricle—coronary artery disease	0.00168	0.0182	CbGeAlD
Ropivacaine—SCN5A—myocardium—coronary artery disease	0.00158	0.0171	CbGeAlD
Ropivacaine—SCN4A—heart—coronary artery disease	0.00142	0.0154	CbGeAlD
Ropivacaine—SCN3A—heart—coronary artery disease	0.0011	0.012	CbGeAlD
Ropivacaine—SCN5A—heart—coronary artery disease	0.0011	0.0119	CbGeAlD
Ropivacaine—SCN5A—cardiovascular system—coronary artery disease	0.00104	0.0112	CbGeAlD
Ropivacaine—SCN5A—cardiac atrium—coronary artery disease	0.000942	0.0102	CbGeAlD
Ropivacaine—SCN2A—blood—coronary artery disease	0.000938	0.0101	CbGeAlD
Ropivacaine—SCN10A—blood—coronary artery disease	0.000905	0.00979	CbGeAlD
Ropivacaine—SCN3A—blood—coronary artery disease	0.000824	0.00892	CbGeAlD
Ropivacaine—SCN5A—blood—coronary artery disease	0.000822	0.00889	CbGeAlD
Ropivacaine—CYP2B6—heart—coronary artery disease	0.000556	0.00601	CbGeAlD
Ropivacaine—CYP2B6—cardiovascular system—coronary artery disease	0.000525	0.00567	CbGeAlD
Ropivacaine—CYP1A2—blood—coronary artery disease	0.000433	0.00468	CbGeAlD
Ropivacaine—CYP2B6—blood—coronary artery disease	0.000415	0.00449	CbGeAlD
Ropivacaine—CYP3A4—blood—coronary artery disease	0.000313	0.00339	CbGeAlD
Ropivacaine—CYP2D6—blood—coronary artery disease	0.000308	0.00333	CbGeAlD
Ropivacaine—Bupivacaine—CYP2C19—coronary artery disease	0.000136	0.704	CrCbGaD
Ropivacaine—Dyspepsia—Losartan—coronary artery disease	9.71e-05	0.000332	CcSEcCtD
Ropivacaine—Feeling abnormal—Perindopril—coronary artery disease	9.69e-05	0.000332	CcSEcCtD
Ropivacaine—Headache—Lovastatin—coronary artery disease	9.67e-05	0.000331	CcSEcCtD
Ropivacaine—Pruritus—Valsartan—coronary artery disease	9.65e-05	0.00033	CcSEcCtD
Ropivacaine—Arthralgia—Timolol—coronary artery disease	9.64e-05	0.00033	CcSEcCtD
Ropivacaine—Myalgia—Timolol—coronary artery disease	9.64e-05	0.00033	CcSEcCtD
Ropivacaine—Chest pain—Timolol—coronary artery disease	9.64e-05	0.00033	CcSEcCtD
Ropivacaine—Vomiting—Ezetimibe—coronary artery disease	9.63e-05	0.00033	CcSEcCtD
Ropivacaine—Hypersensitivity—Pravastatin—coronary artery disease	9.62e-05	0.000329	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Perindopril—coronary artery disease	9.62e-05	0.000329	CcSEcCtD
Ropivacaine—Anxiety—Timolol—coronary artery disease	9.61e-05	0.000329	CcSEcCtD
Ropivacaine—Angioedema—Lisinopril—coronary artery disease	9.6e-05	0.000329	CcSEcCtD
Ropivacaine—Pruritus—Olmesartan—coronary artery disease	9.6e-05	0.000329	CcSEcCtD
Ropivacaine—Abdominal pain—Captopril—coronary artery disease	9.57e-05	0.000328	CcSEcCtD
Ropivacaine—Body temperature increased—Captopril—coronary artery disease	9.57e-05	0.000328	CcSEcCtD
Ropivacaine—Dizziness—Simvastatin—coronary artery disease	9.55e-05	0.000327	CcSEcCtD
Ropivacaine—Rash—Ezetimibe—coronary artery disease	9.55e-05	0.000327	CcSEcCtD
Ropivacaine—Dermatitis—Ezetimibe—coronary artery disease	9.54e-05	0.000327	CcSEcCtD
Ropivacaine—Confusional state—Ramipril—coronary artery disease	9.54e-05	0.000327	CcSEcCtD
Ropivacaine—Discomfort—Timolol—coronary artery disease	9.53e-05	0.000326	CcSEcCtD
Ropivacaine—Asthenia—Niacin—coronary artery disease	9.51e-05	0.000326	CcSEcCtD
Ropivacaine—Headache—Ezetimibe—coronary artery disease	9.49e-05	0.000325	CcSEcCtD
Ropivacaine—Malaise—Lisinopril—coronary artery disease	9.48e-05	0.000325	CcSEcCtD
Ropivacaine—Anaphylactic shock—Ramipril—coronary artery disease	9.46e-05	0.000324	CcSEcCtD
Ropivacaine—Vertigo—Lisinopril—coronary artery disease	9.44e-05	0.000323	CcSEcCtD
Ropivacaine—Constipation—Losartan—coronary artery disease	9.43e-05	0.000323	CcSEcCtD
Ropivacaine—Pain—Losartan—coronary artery disease	9.43e-05	0.000323	CcSEcCtD
Ropivacaine—Syncope—Lisinopril—coronary artery disease	9.42e-05	0.000323	CcSEcCtD
Ropivacaine—Vomiting—Eplerenone—coronary artery disease	9.42e-05	0.000323	CcSEcCtD
Ropivacaine—Feeling abnormal—Furosemide—coronary artery disease	9.42e-05	0.000323	CcSEcCtD
Ropivacaine—Nausea—Fenofibrate—coronary artery disease	9.39e-05	0.000322	CcSEcCtD
Ropivacaine—Pruritus—Niacin—coronary artery disease	9.38e-05	0.000321	CcSEcCtD
Ropivacaine—Asthenia—Pravastatin—coronary artery disease	9.37e-05	0.000321	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Furosemide—coronary artery disease	9.35e-05	0.00032	CcSEcCtD
Ropivacaine—Rash—Eplerenone—coronary artery disease	9.35e-05	0.00032	CcSEcCtD
Ropivacaine—Urticaria—Perindopril—coronary artery disease	9.34e-05	0.00032	CcSEcCtD
Ropivacaine—Hypersensitivity—Trandolapril—coronary artery disease	9.34e-05	0.00032	CcSEcCtD
Ropivacaine—Dermatitis—Eplerenone—coronary artery disease	9.34e-05	0.00032	CcSEcCtD
Ropivacaine—Diarrhoea—Valsartan—coronary artery disease	9.33e-05	0.000319	CcSEcCtD
Ropivacaine—Confusional state—Timolol—coronary artery disease	9.32e-05	0.000319	CcSEcCtD
Ropivacaine—Shock—Ramipril—coronary artery disease	9.3e-05	0.000319	CcSEcCtD
Ropivacaine—Hypersensitivity—Enalapril—coronary artery disease	9.3e-05	0.000319	CcSEcCtD
Ropivacaine—Abdominal pain—Perindopril—coronary artery disease	9.3e-05	0.000318	CcSEcCtD
Ropivacaine—Body temperature increased—Perindopril—coronary artery disease	9.3e-05	0.000318	CcSEcCtD
Ropivacaine—Diarrhoea—Olmesartan—coronary artery disease	9.29e-05	0.000318	CcSEcCtD
Ropivacaine—Headache—Eplerenone—coronary artery disease	9.29e-05	0.000318	CcSEcCtD
Ropivacaine—Thrombocytopenia—Ramipril—coronary artery disease	9.26e-05	0.000317	CcSEcCtD
Ropivacaine—Anaphylactic shock—Timolol—coronary artery disease	9.25e-05	0.000317	CcSEcCtD
Ropivacaine—Pruritus—Pravastatin—coronary artery disease	9.24e-05	0.000316	CcSEcCtD
Ropivacaine—Loss of consciousness—Lisinopril—coronary artery disease	9.24e-05	0.000316	CcSEcCtD
Ropivacaine—Nausea—Clopidogrel—coronary artery disease	9.23e-05	0.000316	CcSEcCtD
Ropivacaine—Tachycardia—Ramipril—coronary artery disease	9.23e-05	0.000316	CcSEcCtD
Ropivacaine—Skin disorder—Ramipril—coronary artery disease	9.19e-05	0.000315	CcSEcCtD
Ropivacaine—Infection—Timolol—coronary artery disease	9.19e-05	0.000315	CcSEcCtD
Ropivacaine—Vomiting—Simvastatin—coronary artery disease	9.18e-05	0.000314	CcSEcCtD
Ropivacaine—Hypersensitivity—Telmisartan—coronary artery disease	9.18e-05	0.000314	CcSEcCtD
Ropivacaine—Cough—Lisinopril—coronary artery disease	9.17e-05	0.000314	CcSEcCtD
Ropivacaine—Nausea—Lovastatin—coronary artery disease	9.17e-05	0.000314	CcSEcCtD
Ropivacaine—Hyperhidrosis—Ramipril—coronary artery disease	9.14e-05	0.000313	CcSEcCtD
Ropivacaine—Rash—Simvastatin—coronary artery disease	9.11e-05	0.000312	CcSEcCtD
Ropivacaine—Dermatitis—Simvastatin—coronary artery disease	9.1e-05	0.000311	CcSEcCtD
Ropivacaine—Asthenia—Trandolapril—coronary artery disease	9.1e-05	0.000311	CcSEcCtD
Ropivacaine—Shock—Timolol—coronary artery disease	9.1e-05	0.000311	CcSEcCtD
Ropivacaine—Feeling abnormal—Losartan—coronary artery disease	9.09e-05	0.000311	CcSEcCtD
Ropivacaine—Urticaria—Furosemide—coronary artery disease	9.08e-05	0.000311	CcSEcCtD
Ropivacaine—Diarrhoea—Niacin—coronary artery disease	9.07e-05	0.000311	CcSEcCtD
Ropivacaine—Asthenia—Enalapril—coronary artery disease	9.06e-05	0.00031	CcSEcCtD
Ropivacaine—Headache—Simvastatin—coronary artery disease	9.05e-05	0.00031	CcSEcCtD
Ropivacaine—Abdominal pain—Furosemide—coronary artery disease	9.04e-05	0.000309	CcSEcCtD
Ropivacaine—Body temperature increased—Furosemide—coronary artery disease	9.04e-05	0.000309	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Losartan—coronary artery disease	9.02e-05	0.000309	CcSEcCtD
Ropivacaine—Dizziness—Valsartan—coronary artery disease	9.02e-05	0.000309	CcSEcCtD
Ropivacaine—Nausea—Ezetimibe—coronary artery disease	8.99e-05	0.000308	CcSEcCtD
Ropivacaine—Skin disorder—Timolol—coronary artery disease	8.98e-05	0.000307	CcSEcCtD
Ropivacaine—Dizziness—Olmesartan—coronary artery disease	8.97e-05	0.000307	CcSEcCtD
Ropivacaine—Pruritus—Trandolapril—coronary artery disease	8.97e-05	0.000307	CcSEcCtD
Ropivacaine—Chest pain—Lisinopril—coronary artery disease	8.95e-05	0.000306	CcSEcCtD
Ropivacaine—Arthralgia—Lisinopril—coronary artery disease	8.95e-05	0.000306	CcSEcCtD
Ropivacaine—Myalgia—Lisinopril—coronary artery disease	8.95e-05	0.000306	CcSEcCtD
Ropivacaine—Hyperhidrosis—Timolol—coronary artery disease	8.94e-05	0.000306	CcSEcCtD
Ropivacaine—Asthenia—Telmisartan—coronary artery disease	8.94e-05	0.000306	CcSEcCtD
Ropivacaine—Pruritus—Enalapril—coronary artery disease	8.93e-05	0.000306	CcSEcCtD
Ropivacaine—Diarrhoea—Pravastatin—coronary artery disease	8.93e-05	0.000306	CcSEcCtD
Ropivacaine—Anxiety—Lisinopril—coronary artery disease	8.92e-05	0.000305	CcSEcCtD
Ropivacaine—Discomfort—Lisinopril—coronary artery disease	8.84e-05	0.000303	CcSEcCtD
Ropivacaine—Hypotension—Ramipril—coronary artery disease	8.84e-05	0.000303	CcSEcCtD
Ropivacaine—Pruritus—Telmisartan—coronary artery disease	8.81e-05	0.000302	CcSEcCtD
Ropivacaine—Nausea—Eplerenone—coronary artery disease	8.8e-05	0.000301	CcSEcCtD
Ropivacaine—Dizziness—Niacin—coronary artery disease	8.77e-05	0.0003	CcSEcCtD
Ropivacaine—Urticaria—Losartan—coronary artery disease	8.76e-05	0.0003	CcSEcCtD
Ropivacaine—Abdominal pain—Losartan—coronary artery disease	8.72e-05	0.000299	CcSEcCtD
Ropivacaine—Body temperature increased—Losartan—coronary artery disease	8.72e-05	0.000299	CcSEcCtD
Ropivacaine—Asthenia—Captopril—coronary artery disease	8.69e-05	0.000298	CcSEcCtD
Ropivacaine—Diarrhoea—Trandolapril—coronary artery disease	8.67e-05	0.000297	CcSEcCtD
Ropivacaine—Vomiting—Valsartan—coronary artery disease	8.67e-05	0.000297	CcSEcCtD
Ropivacaine—Confusional state—Lisinopril—coronary artery disease	8.65e-05	0.000296	CcSEcCtD
Ropivacaine—Diarrhoea—Enalapril—coronary artery disease	8.64e-05	0.000296	CcSEcCtD
Ropivacaine—Hypotension—Timolol—coronary artery disease	8.64e-05	0.000296	CcSEcCtD
Ropivacaine—Dizziness—Pravastatin—coronary artery disease	8.63e-05	0.000296	CcSEcCtD
Ropivacaine—Vomiting—Olmesartan—coronary artery disease	8.63e-05	0.000295	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.62e-05	0.000295	CcSEcCtD
Ropivacaine—Rash—Valsartan—coronary artery disease	8.6e-05	0.000294	CcSEcCtD
Ropivacaine—Dermatitis—Valsartan—coronary artery disease	8.59e-05	0.000294	CcSEcCtD
Ropivacaine—Nausea—Simvastatin—coronary artery disease	8.58e-05	0.000294	CcSEcCtD
Ropivacaine—Anaphylactic shock—Lisinopril—coronary artery disease	8.58e-05	0.000294	CcSEcCtD
Ropivacaine—Pruritus—Captopril—coronary artery disease	8.57e-05	0.000293	CcSEcCtD
Ropivacaine—Rash—Olmesartan—coronary artery disease	8.56e-05	0.000293	CcSEcCtD
Ropivacaine—Insomnia—Ramipril—coronary artery disease	8.55e-05	0.000293	CcSEcCtD
Ropivacaine—Dermatitis—Olmesartan—coronary artery disease	8.55e-05	0.000293	CcSEcCtD
Ropivacaine—Headache—Valsartan—coronary artery disease	8.54e-05	0.000293	CcSEcCtD
Ropivacaine—Diarrhoea—Telmisartan—coronary artery disease	8.52e-05	0.000292	CcSEcCtD
Ropivacaine—Infection—Lisinopril—coronary artery disease	8.52e-05	0.000292	CcSEcCtD
Ropivacaine—Headache—Olmesartan—coronary artery disease	8.5e-05	0.000291	CcSEcCtD
Ropivacaine—Paraesthesia—Ramipril—coronary artery disease	8.49e-05	0.000291	CcSEcCtD
Ropivacaine—Shock—Lisinopril—coronary artery disease	8.44e-05	0.000289	CcSEcCtD
Ropivacaine—Asthenia—Perindopril—coronary artery disease	8.44e-05	0.000289	CcSEcCtD
Ropivacaine—Dyspnoea—Ramipril—coronary artery disease	8.43e-05	0.000289	CcSEcCtD
Ropivacaine—Vomiting—Niacin—coronary artery disease	8.43e-05	0.000289	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Timolol—coronary artery disease	8.42e-05	0.000288	CcSEcCtD
Ropivacaine—Hypersensitivity—Furosemide—coronary artery disease	8.42e-05	0.000288	CcSEcCtD
Ropivacaine—Somnolence—Ramipril—coronary artery disease	8.41e-05	0.000288	CcSEcCtD
Ropivacaine—Thrombocytopenia—Lisinopril—coronary artery disease	8.4e-05	0.000288	CcSEcCtD
Ropivacaine—Dizziness—Trandolapril—coronary artery disease	8.38e-05	0.000287	CcSEcCtD
Ropivacaine—Tachycardia—Lisinopril—coronary artery disease	8.37e-05	0.000287	CcSEcCtD
Ropivacaine—Insomnia—Timolol—coronary artery disease	8.36e-05	0.000286	CcSEcCtD
Ropivacaine—Rash—Niacin—coronary artery disease	8.36e-05	0.000286	CcSEcCtD
Ropivacaine—Dermatitis—Niacin—coronary artery disease	8.35e-05	0.000286	CcSEcCtD
Ropivacaine—Dizziness—Enalapril—coronary artery disease	8.35e-05	0.000286	CcSEcCtD
Ropivacaine—Skin disorder—Lisinopril—coronary artery disease	8.33e-05	0.000285	CcSEcCtD
Ropivacaine—Dyspepsia—Ramipril—coronary artery disease	8.33e-05	0.000285	CcSEcCtD
Ropivacaine—Pruritus—Perindopril—coronary artery disease	8.32e-05	0.000285	CcSEcCtD
Ropivacaine—Headache—Niacin—coronary artery disease	8.31e-05	0.000284	CcSEcCtD
Ropivacaine—Paraesthesia—Timolol—coronary artery disease	8.3e-05	0.000284	CcSEcCtD
Ropivacaine—Vomiting—Pravastatin—coronary artery disease	8.3e-05	0.000284	CcSEcCtD
Ropivacaine—Hyperhidrosis—Lisinopril—coronary artery disease	8.29e-05	0.000284	CcSEcCtD
Ropivacaine—Diarrhoea—Captopril—coronary artery disease	8.29e-05	0.000284	CcSEcCtD
Ropivacaine—Dyspnoea—Timolol—coronary artery disease	8.24e-05	0.000282	CcSEcCtD
Ropivacaine—Dizziness—Telmisartan—coronary artery disease	8.24e-05	0.000282	CcSEcCtD
Ropivacaine—Rash—Pravastatin—coronary artery disease	8.23e-05	0.000282	CcSEcCtD
Ropivacaine—Dermatitis—Pravastatin—coronary artery disease	8.22e-05	0.000282	CcSEcCtD
Ropivacaine—Somnolence—Timolol—coronary artery disease	8.22e-05	0.000281	CcSEcCtD
Ropivacaine—Asthenia—Furosemide—coronary artery disease	8.2e-05	0.000281	CcSEcCtD
Ropivacaine—Headache—Pravastatin—coronary artery disease	8.18e-05	0.00028	CcSEcCtD
Ropivacaine—Dyspepsia—Timolol—coronary artery disease	8.14e-05	0.000279	CcSEcCtD
Ropivacaine—Hypersensitivity—Losartan—coronary artery disease	8.13e-05	0.000278	CcSEcCtD
Ropivacaine—Nausea—Valsartan—coronary artery disease	8.1e-05	0.000277	CcSEcCtD
Ropivacaine—Pruritus—Furosemide—coronary artery disease	8.09e-05	0.000277	CcSEcCtD
Ropivacaine—Constipation—Ramipril—coronary artery disease	8.09e-05	0.000277	CcSEcCtD
Ropivacaine—Nausea—Olmesartan—coronary artery disease	8.06e-05	0.000276	CcSEcCtD
Ropivacaine—Vomiting—Trandolapril—coronary artery disease	8.06e-05	0.000276	CcSEcCtD
Ropivacaine—Diarrhoea—Perindopril—coronary artery disease	8.05e-05	0.000275	CcSEcCtD
Ropivacaine—Vomiting—Enalapril—coronary artery disease	8.03e-05	0.000275	CcSEcCtD
Ropivacaine—Hypotension—Lisinopril—coronary artery disease	8.01e-05	0.000274	CcSEcCtD
Ropivacaine—Dizziness—Captopril—coronary artery disease	8.01e-05	0.000274	CcSEcCtD
Ropivacaine—Rash—Trandolapril—coronary artery disease	7.99e-05	0.000274	CcSEcCtD
Ropivacaine—Dermatitis—Trandolapril—coronary artery disease	7.99e-05	0.000273	CcSEcCtD
Ropivacaine—Rash—Enalapril—coronary artery disease	7.96e-05	0.000273	CcSEcCtD
Ropivacaine—Dermatitis—Enalapril—coronary artery disease	7.95e-05	0.000272	CcSEcCtD
Ropivacaine—Headache—Trandolapril—coronary artery disease	7.94e-05	0.000272	CcSEcCtD
Ropivacaine—Vomiting—Telmisartan—coronary artery disease	7.92e-05	0.000271	CcSEcCtD
Ropivacaine—Asthenia—Losartan—coronary artery disease	7.91e-05	0.000271	CcSEcCtD
Ropivacaine—Headache—Enalapril—coronary artery disease	7.91e-05	0.000271	CcSEcCtD
Ropivacaine—Pain—Timolol—coronary artery disease	7.91e-05	0.000271	CcSEcCtD
Ropivacaine—Nausea—Niacin—coronary artery disease	7.88e-05	0.00027	CcSEcCtD
Ropivacaine—Rash—Telmisartan—coronary artery disease	7.85e-05	0.000269	CcSEcCtD
Ropivacaine—Dermatitis—Telmisartan—coronary artery disease	7.85e-05	0.000269	CcSEcCtD
Ropivacaine—Diarrhoea—Furosemide—coronary artery disease	7.82e-05	0.000268	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.81e-05	0.000268	CcSEcCtD
Ropivacaine—Pruritus—Losartan—coronary artery disease	7.8e-05	0.000267	CcSEcCtD
Ropivacaine—Headache—Telmisartan—coronary artery disease	7.8e-05	0.000267	CcSEcCtD
Ropivacaine—Feeling abnormal—Ramipril—coronary artery disease	7.79e-05	0.000267	CcSEcCtD
Ropivacaine—Dizziness—Perindopril—coronary artery disease	7.78e-05	0.000266	CcSEcCtD
Ropivacaine—Insomnia—Lisinopril—coronary artery disease	7.76e-05	0.000266	CcSEcCtD
Ropivacaine—Nausea—Pravastatin—coronary artery disease	7.76e-05	0.000266	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Ramipril—coronary artery disease	7.73e-05	0.000265	CcSEcCtD
Ropivacaine—Paraesthesia—Lisinopril—coronary artery disease	7.7e-05	0.000264	CcSEcCtD
Ropivacaine—Vomiting—Captopril—coronary artery disease	7.7e-05	0.000264	CcSEcCtD
Ropivacaine—Dyspnoea—Lisinopril—coronary artery disease	7.65e-05	0.000262	CcSEcCtD
Ropivacaine—Rash—Captopril—coronary artery disease	7.64e-05	0.000261	CcSEcCtD
Ropivacaine—Dermatitis—Captopril—coronary artery disease	7.63e-05	0.000261	CcSEcCtD
Ropivacaine—Somnolence—Lisinopril—coronary artery disease	7.63e-05	0.000261	CcSEcCtD
Ropivacaine—Feeling abnormal—Timolol—coronary artery disease	7.62e-05	0.000261	CcSEcCtD
Ropivacaine—Headache—Captopril—coronary artery disease	7.59e-05	0.00026	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Timolol—coronary artery disease	7.56e-05	0.000259	CcSEcCtD
Ropivacaine—Dizziness—Furosemide—coronary artery disease	7.56e-05	0.000259	CcSEcCtD
Ropivacaine—Dyspepsia—Lisinopril—coronary artery disease	7.55e-05	0.000259	CcSEcCtD
Ropivacaine—Diarrhoea—Losartan—coronary artery disease	7.55e-05	0.000258	CcSEcCtD
Ropivacaine—Nausea—Trandolapril—coronary artery disease	7.53e-05	0.000258	CcSEcCtD
Ropivacaine—Urticaria—Ramipril—coronary artery disease	7.51e-05	0.000257	CcSEcCtD
Ropivacaine—Nausea—Enalapril—coronary artery disease	7.5e-05	0.000257	CcSEcCtD
Ropivacaine—Vomiting—Perindopril—coronary artery disease	7.48e-05	0.000256	CcSEcCtD
Ropivacaine—Abdominal pain—Ramipril—coronary artery disease	7.48e-05	0.000256	CcSEcCtD
Ropivacaine—Body temperature increased—Ramipril—coronary artery disease	7.48e-05	0.000256	CcSEcCtD
Ropivacaine—Rash—Perindopril—coronary artery disease	7.41e-05	0.000254	CcSEcCtD
Ropivacaine—Dermatitis—Perindopril—coronary artery disease	7.41e-05	0.000254	CcSEcCtD
Ropivacaine—Nausea—Telmisartan—coronary artery disease	7.4e-05	0.000253	CcSEcCtD
Ropivacaine—Headache—Perindopril—coronary artery disease	7.37e-05	0.000252	CcSEcCtD
Ropivacaine—Urticaria—Timolol—coronary artery disease	7.34e-05	0.000251	CcSEcCtD
Ropivacaine—Pain—Lisinopril—coronary artery disease	7.33e-05	0.000251	CcSEcCtD
Ropivacaine—Constipation—Lisinopril—coronary artery disease	7.33e-05	0.000251	CcSEcCtD
Ropivacaine—Abdominal pain—Timolol—coronary artery disease	7.31e-05	0.00025	CcSEcCtD
Ropivacaine—Body temperature increased—Timolol—coronary artery disease	7.31e-05	0.00025	CcSEcCtD
Ropivacaine—Dizziness—Losartan—coronary artery disease	7.29e-05	0.00025	CcSEcCtD
Ropivacaine—Vomiting—Furosemide—coronary artery disease	7.27e-05	0.000249	CcSEcCtD
Ropivacaine—Rash—Furosemide—coronary artery disease	7.21e-05	0.000247	CcSEcCtD
Ropivacaine—Dermatitis—Furosemide—coronary artery disease	7.2e-05	0.000247	CcSEcCtD
Ropivacaine—Nausea—Captopril—coronary artery disease	7.19e-05	0.000246	CcSEcCtD
Ropivacaine—Headache—Furosemide—coronary artery disease	7.16e-05	0.000245	CcSEcCtD
Ropivacaine—Feeling abnormal—Lisinopril—coronary artery disease	7.07e-05	0.000242	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Lisinopril—coronary artery disease	7.01e-05	0.00024	CcSEcCtD
Ropivacaine—Vomiting—Losartan—coronary artery disease	7.01e-05	0.00024	CcSEcCtD
Ropivacaine—Nausea—Perindopril—coronary artery disease	6.98e-05	0.000239	CcSEcCtD
Ropivacaine—Hypersensitivity—Ramipril—coronary artery disease	6.97e-05	0.000239	CcSEcCtD
Ropivacaine—Rash—Losartan—coronary artery disease	6.95e-05	0.000238	CcSEcCtD
Ropivacaine—Dermatitis—Losartan—coronary artery disease	6.95e-05	0.000238	CcSEcCtD
Ropivacaine—Headache—Losartan—coronary artery disease	6.91e-05	0.000237	CcSEcCtD
Ropivacaine—Urticaria—Lisinopril—coronary artery disease	6.81e-05	0.000233	CcSEcCtD
Ropivacaine—Hypersensitivity—Timolol—coronary artery disease	6.81e-05	0.000233	CcSEcCtD
Ropivacaine—Nausea—Furosemide—coronary artery disease	6.79e-05	0.000232	CcSEcCtD
Ropivacaine—Asthenia—Ramipril—coronary artery disease	6.79e-05	0.000232	CcSEcCtD
Ropivacaine—Abdominal pain—Lisinopril—coronary artery disease	6.78e-05	0.000232	CcSEcCtD
Ropivacaine—Body temperature increased—Lisinopril—coronary artery disease	6.78e-05	0.000232	CcSEcCtD
Ropivacaine—Pruritus—Ramipril—coronary artery disease	6.69e-05	0.000229	CcSEcCtD
Ropivacaine—Asthenia—Timolol—coronary artery disease	6.63e-05	0.000227	CcSEcCtD
Ropivacaine—Nausea—Losartan—coronary artery disease	6.55e-05	0.000224	CcSEcCtD
Ropivacaine—Pruritus—Timolol—coronary artery disease	6.54e-05	0.000224	CcSEcCtD
Ropivacaine—Diarrhoea—Ramipril—coronary artery disease	6.47e-05	0.000222	CcSEcCtD
Ropivacaine—Diarrhoea—Timolol—coronary artery disease	6.33e-05	0.000217	CcSEcCtD
Ropivacaine—Hypersensitivity—Lisinopril—coronary artery disease	6.32e-05	0.000216	CcSEcCtD
Ropivacaine—Dizziness—Ramipril—coronary artery disease	6.25e-05	0.000214	CcSEcCtD
Ropivacaine—Asthenia—Lisinopril—coronary artery disease	6.15e-05	0.000211	CcSEcCtD
Ropivacaine—Dizziness—Timolol—coronary artery disease	6.11e-05	0.000209	CcSEcCtD
Ropivacaine—Pruritus—Lisinopril—coronary artery disease	6.07e-05	0.000208	CcSEcCtD
Ropivacaine—Vomiting—Ramipril—coronary artery disease	6.01e-05	0.000206	CcSEcCtD
Ropivacaine—Rash—Ramipril—coronary artery disease	5.96e-05	0.000204	CcSEcCtD
Ropivacaine—Dermatitis—Ramipril—coronary artery disease	5.96e-05	0.000204	CcSEcCtD
Ropivacaine—Headache—Ramipril—coronary artery disease	5.92e-05	0.000203	CcSEcCtD
Ropivacaine—Vomiting—Timolol—coronary artery disease	5.88e-05	0.000201	CcSEcCtD
Ropivacaine—Diarrhoea—Lisinopril—coronary artery disease	5.87e-05	0.000201	CcSEcCtD
Ropivacaine—Rash—Timolol—coronary artery disease	5.83e-05	0.0002	CcSEcCtD
Ropivacaine—Dermatitis—Timolol—coronary artery disease	5.82e-05	0.000199	CcSEcCtD
Ropivacaine—Headache—Timolol—coronary artery disease	5.79e-05	0.000198	CcSEcCtD
Ropivacaine—Tocainide—ALB—coronary artery disease	5.72e-05	0.296	CrCbGaD
Ropivacaine—Dizziness—Lisinopril—coronary artery disease	5.67e-05	0.000194	CcSEcCtD
Ropivacaine—Nausea—Ramipril—coronary artery disease	5.62e-05	0.000192	CcSEcCtD
Ropivacaine—Nausea—Timolol—coronary artery disease	5.49e-05	0.000188	CcSEcCtD
Ropivacaine—Vomiting—Lisinopril—coronary artery disease	5.45e-05	0.000187	CcSEcCtD
Ropivacaine—Rash—Lisinopril—coronary artery disease	5.41e-05	0.000185	CcSEcCtD
Ropivacaine—Dermatitis—Lisinopril—coronary artery disease	5.4e-05	0.000185	CcSEcCtD
Ropivacaine—Headache—Lisinopril—coronary artery disease	5.37e-05	0.000184	CcSEcCtD
Ropivacaine—Nausea—Lisinopril—coronary artery disease	5.09e-05	0.000174	CcSEcCtD
Ropivacaine—CYP3A4—Metabolism—PGM1—coronary artery disease	9.7e-06	9.77e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	9.68e-06	9.75e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOA2—coronary artery disease	9.68e-06	9.75e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPX2—coronary artery disease	9.68e-06	9.75e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPX4—coronary artery disease	9.56e-06	9.63e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCG5—coronary artery disease	9.56e-06	9.63e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HK1—coronary artery disease	9.56e-06	9.63e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SULT1A1—coronary artery disease	9.56e-06	9.63e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOA4—coronary artery disease	9.52e-06	9.59e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PSMB5—coronary artery disease	9.51e-06	9.58e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PSMA6—coronary artery disease	9.51e-06	9.58e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HADHA—coronary artery disease	9.44e-06	9.51e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CKB—coronary artery disease	9.37e-06	9.44e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PYGB—coronary artery disease	9.37e-06	9.44e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	9.35e-06	9.42e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTA1—coronary artery disease	9.34e-06	9.4e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CTGF—coronary artery disease	9.29e-06	9.36e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LPA—coronary artery disease	9.23e-06	9.3e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMGCR—coronary artery disease	9.21e-06	9.27e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GOT2—coronary artery disease	9.21e-06	9.27e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PDHA1—coronary artery disease	9.2e-06	9.27e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GCLM—coronary artery disease	9.2e-06	9.27e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLCB3—coronary artery disease	8.94e-06	9.01e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	8.91e-06	8.98e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TXNRD1—coronary artery disease	8.91e-06	8.97e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP11B2—coronary artery disease	8.91e-06	8.97e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOA5—coronary artery disease	8.85e-06	8.92e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—COX5B—coronary artery disease	8.81e-06	8.87e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLIN1—coronary artery disease	8.81e-06	8.87e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTM2—coronary artery disease	8.81e-06	8.87e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	8.81e-06	8.87e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—DLAT—coronary artery disease	8.81e-06	8.87e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC22A3—coronary artery disease	8.77e-06	8.84e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—P4HB—coronary artery disease	8.68e-06	8.74e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HADH—coronary artery disease	8.65e-06	8.71e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ARNTL—coronary artery disease	8.65e-06	8.71e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	8.52e-06	8.58e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	8.51e-06	8.58e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLCB1—coronary artery disease	8.46e-06	8.53e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	8.35e-06	8.41e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	8.3e-06	8.37e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCA1—coronary artery disease	8.2e-06	8.27e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	8.2e-06	8.26e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOA2—coronary artery disease	8.2e-06	8.26e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPX2—coronary artery disease	8.2e-06	8.26e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HK1—coronary artery disease	8.1e-06	8.16e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SULT1A1—coronary artery disease	8.1e-06	8.16e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPX4—coronary artery disease	8.1e-06	8.16e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCG5—coronary artery disease	8.1e-06	8.16e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	8.09e-06	8.15e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—VCAN—coronary artery disease	8.03e-06	8.09e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HADHA—coronary artery disease	8e-06	8.06e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALDOA—coronary artery disease	7.97e-06	8.03e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	7.96e-06	8.02e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HK2—coronary artery disease	7.96e-06	8.02e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GGT1—coronary artery disease	7.95e-06	8.01e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GOT1—coronary artery disease	7.95e-06	8.01e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTA1—coronary artery disease	7.91e-06	7.97e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LPA—coronary artery disease	7.82e-06	7.88e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—DCN—coronary artery disease	7.74e-06	7.79e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	7.63e-06	7.69e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLCB3—coronary artery disease	7.57e-06	7.63e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALDH2—coronary artery disease	7.52e-06	7.58e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOA5—coronary artery disease	7.5e-06	7.55e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LCAT—coronary artery disease	7.49e-06	7.54e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CPT1B—coronary artery disease	7.49e-06	7.54e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—P4HB—coronary artery disease	7.35e-06	7.41e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOA4—coronary artery disease	7.35e-06	7.4e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LIPC—coronary artery disease	7.33e-06	7.39e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HBA1—coronary artery disease	7.33e-06	7.39e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	7.33e-06	7.39e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	7.33e-06	7.39e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOC3—coronary artery disease	7.29e-06	7.34e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	7.28e-06	7.34e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LDLR—coronary artery disease	7.24e-06	7.3e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	7.22e-06	7.27e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	7.16e-06	7.21e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTT1—coronary artery disease	7.16e-06	7.21e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTP1—coronary artery disease	7.14e-06	7.19e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.14e-06	7.19e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PDHA1—coronary artery disease	7.1e-06	7.15e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GCLM—coronary artery disease	7.1e-06	7.15e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CETP—coronary artery disease	7.07e-06	7.13e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GCLC—coronary artery disease	7.07e-06	7.13e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARGC1A—coronary artery disease	7.07e-06	7.12e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.05e-06	7.11e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMOX1—coronary artery disease	7.04e-06	7.09e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SDC1—coronary artery disease	7e-06	7.05e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CAT—coronary artery disease	6.95e-06	7e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	6.87e-06	6.93e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	6.87e-06	6.93e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—VCAN—coronary artery disease	6.8e-06	6.85e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	6.77e-06	6.82e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALDOA—coronary artery disease	6.75e-06	6.8e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOB—coronary artery disease	6.74e-06	6.79e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HADH—coronary artery disease	6.67e-06	6.72e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ARNTL—coronary artery disease	6.67e-06	6.72e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PSMB5—coronary artery disease	6.61e-06	6.66e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PSMA6—coronary artery disease	6.61e-06	6.66e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTM1—coronary artery disease	6.56e-06	6.61e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—DCN—coronary artery disease	6.55e-06	6.6e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CTGF—coronary artery disease	6.46e-06	6.5e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—LPL—coronary artery disease	6.44e-06	6.49e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMGCR—coronary artery disease	6.4e-06	6.45e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GOT2—coronary artery disease	6.4e-06	6.45e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALDH2—coronary artery disease	6.37e-06	6.42e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOA2—coronary artery disease	6.33e-06	6.37e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	6.33e-06	6.37e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPX2—coronary artery disease	6.33e-06	6.37e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPX1—coronary artery disease	6.28e-06	6.33e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCG5—coronary artery disease	6.25e-06	6.3e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPX4—coronary artery disease	6.25e-06	6.3e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HK1—coronary artery disease	6.25e-06	6.3e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	6.25e-06	6.3e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.21e-06	6.26e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LIPC—coronary artery disease	6.21e-06	6.26e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HBA1—coronary artery disease	6.21e-06	6.26e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2C19—coronary artery disease	6.21e-06	6.26e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	6.21e-06	6.26e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HADHA—coronary artery disease	6.17e-06	6.22e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOC3—coronary artery disease	6.17e-06	6.22e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LDLR—coronary artery disease	6.14e-06	6.18e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.13e-06	6.18e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CD36—coronary artery disease	6.12e-06	6.16e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTA1—coronary artery disease	6.1e-06	6.15e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTT1—coronary artery disease	6.06e-06	6.11e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC9A1—coronary artery disease	6.06e-06	6.11e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPP2CA—coronary artery disease	6.04e-06	6.09e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LPA—coronary artery disease	6.03e-06	6.08e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CETP—coronary artery disease	5.99e-06	6.04e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GCLC—coronary artery disease	5.99e-06	6.04e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SDC1—coronary artery disease	5.93e-06	5.97e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLCB1—coronary artery disease	5.88e-06	5.93e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.84e-06	5.89e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—coronary artery disease	5.8e-06	5.84e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOA5—coronary artery disease	5.79e-06	5.83e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCA1—coronary artery disease	5.7e-06	5.75e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—P4HB—coronary artery disease	5.67e-06	5.72e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PSMA6—coronary artery disease	5.6e-06	5.64e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PSMB5—coronary artery disease	5.6e-06	5.64e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.59e-06	5.63e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	5.57e-06	5.61e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GGT1—coronary artery disease	5.52e-06	5.56e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GOT1—coronary artery disease	5.52e-06	5.56e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AGT—coronary artery disease	5.51e-06	5.55e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CTGF—coronary artery disease	5.47e-06	5.51e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMGCR—coronary artery disease	5.42e-06	5.46e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GOT2—coronary artery disease	5.42e-06	5.46e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOE—coronary artery disease	5.4e-06	5.44e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOA1—coronary artery disease	5.33e-06	5.37e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—VCAN—coronary artery disease	5.25e-06	5.29e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALDOA—coronary artery disease	5.21e-06	5.25e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—DCN—coronary artery disease	5.06e-06	5.1e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLCB1—coronary artery disease	4.98e-06	5.02e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTP1—coronary artery disease	4.96e-06	5e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.92e-06	4.96e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	4.92e-06	4.95e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMOX1—coronary artery disease	4.89e-06	4.93e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.89e-06	4.93e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCA1—coronary artery disease	4.83e-06	4.87e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CAT—coronary artery disease	4.83e-06	4.86e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LIPC—coronary artery disease	4.79e-06	4.83e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HBA1—coronary artery disease	4.79e-06	4.83e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.79e-06	4.83e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.79e-06	4.83e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOC3—coronary artery disease	4.76e-06	4.8e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LDLR—coronary artery disease	4.74e-06	4.77e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARG—coronary artery disease	4.7e-06	4.74e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOB—coronary artery disease	4.69e-06	4.72e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.68e-06	4.71e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.68e-06	4.71e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GGT1—coronary artery disease	4.68e-06	4.71e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GOT1—coronary artery disease	4.68e-06	4.71e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—POMC—coronary artery disease	4.64e-06	4.67e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CETP—coronary artery disease	4.63e-06	4.66e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GCLC—coronary artery disease	4.63e-06	4.66e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SDC1—coronary artery disease	4.57e-06	4.61e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTM1—coronary artery disease	4.56e-06	4.59e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—LPL—coronary artery disease	4.47e-06	4.51e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPX1—coronary artery disease	4.37e-06	4.4e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PSMA6—coronary artery disease	4.32e-06	4.35e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PSMB5—coronary artery disease	4.32e-06	4.35e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CD36—coronary artery disease	4.25e-06	4.28e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALB—coronary artery disease	4.23e-06	4.26e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CTGF—coronary artery disease	4.22e-06	4.25e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTP1—coronary artery disease	4.2e-06	4.23e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	4.2e-06	4.23e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMGCR—coronary artery disease	4.18e-06	4.21e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GOT2—coronary artery disease	4.18e-06	4.21e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	4.16e-06	4.19e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMOX1—coronary artery disease	4.14e-06	4.18e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CAT—coronary artery disease	4.09e-06	4.12e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NOS3—coronary artery disease	4.04e-06	4.07e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.03e-06	4.06e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOB—coronary artery disease	3.97e-06	4e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTM1—coronary artery disease	3.86e-06	3.89e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.85e-06	3.88e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AGT—coronary artery disease	3.83e-06	3.86e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—LPL—coronary artery disease	3.79e-06	3.82e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOE—coronary artery disease	3.75e-06	3.78e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.73e-06	3.76e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOA1—coronary artery disease	3.71e-06	3.74e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPX1—coronary artery disease	3.7e-06	3.73e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—coronary artery disease	3.7e-06	3.73e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GOT1—coronary artery disease	3.61e-06	3.64e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GGT1—coronary artery disease	3.61e-06	3.64e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CD36—coronary artery disease	3.6e-06	3.63e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	3.56e-06	3.58e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—coronary artery disease	3.41e-06	3.44e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARG—coronary artery disease	3.27e-06	3.29e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.24e-06	3.27e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AGT—coronary artery disease	3.24e-06	3.27e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—POMC—coronary artery disease	3.22e-06	3.25e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.21e-06	3.24e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.2e-06	3.22e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOE—coronary artery disease	3.18e-06	3.2e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CAT—coronary artery disease	3.16e-06	3.18e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOA1—coronary artery disease	3.14e-06	3.16e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOB—coronary artery disease	3.06e-06	3.09e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.01e-06	3.03e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.98e-06	3e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALB—coronary artery disease	2.94e-06	2.96e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—LPL—coronary artery disease	2.93e-06	2.95e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPX1—coronary artery disease	2.85e-06	2.88e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NOS3—coronary artery disease	2.81e-06	2.83e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CD36—coronary artery disease	2.78e-06	2.8e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARG—coronary artery disease	2.77e-06	2.79e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.75e-06	2.77e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—POMC—coronary artery disease	2.73e-06	2.75e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.63e-06	2.65e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.57e-06	2.59e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AGT—coronary artery disease	2.5e-06	2.52e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALB—coronary artery disease	2.49e-06	2.51e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOE—coronary artery disease	2.45e-06	2.47e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOA1—coronary artery disease	2.42e-06	2.44e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NOS3—coronary artery disease	2.38e-06	2.4e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CA—coronary artery disease	2.28e-06	2.29e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—coronary artery disease	2.18e-06	2.19e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARG—coronary artery disease	2.14e-06	2.15e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—POMC—coronary artery disease	2.11e-06	2.12e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALB—coronary artery disease	1.92e-06	1.94e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—coronary artery disease	1.86e-06	1.87e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.84e-06	1.85e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.68e-06	1.69e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.58e-06	1.59e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.34e-06	1.35e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.29e-06	1.3e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—coronary artery disease	1.09e-06	1.1e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.03e-06	1.04e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—coronary artery disease	8.45e-07	8.51e-06	CbGpPWpGaD
